Trials / Recruiting
RecruitingNCT05733416
Intensive Cancer Screening After Cryptogenic Stroke
Intensive Cancer Screening After Cryptogenic Stroke (INCOGNITO) Pilot Randomized Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Ottawa Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The INCOGNITO Pilot Trial is a single centre pilot prospective randomized open-label blinded endpoint (PROBE) trial to assess the feasibility of a full-scale randomized trial to determine whether an occult cancer screening strategy of FDG PET/CT (F-fluorodeoxyglucose positron emission/computed tomography) in addition to usual care increases the number of occult cancers diagnosed after screening compared to usual care cancer screening alone in patients with cryptogenic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | FDG PET/CT | F-fluorodeoxyglucose positron emission/computed tomography |
| DIAGNOSTIC_TEST | Usual Care | Cancer screening according to sex, age and risk as per Canadian Task Force on Preventative Health Care |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2027-01-01
- Completion
- 2027-01-01
- First posted
- 2023-02-17
- Last updated
- 2025-07-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05733416. Inclusion in this directory is not an endorsement.